FOXP3 facilitates the invasion and metastasis of non-small cell lung cancer cells through regulating VEGF, EMT and the Notch1/Hes1 pathway
Article in Experimental and Therapeutic Medicine (July 2021)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Understanding clinical practice and survival outcomes in patients with unresectable stage III non-small-cell lung cancer in a single centre in Quebec
Article in Current Oncology (October 2020)
Epigallocatechin‐3‐gallate inhibited cancer stem cell–like properties by targeting hsa‐mir‐485‐5p/RXRα in lung cancer
Article in Journal of Cellular Biochemistry (July 2018)